Cornercap Investment Counsel’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.33M Sell
3,808
-52
-1% -$17.6K 0.66% 79
2025
Q3
$1.25M Sell
3,860
-65
-2% -$20.2K 0.62% 85
2025
Q2
$1.53M Sell
3,925
-84
-2% -$33.8K 0.8% 46
2025
Q1
$1.74M Buy
+4,009
New +$1.61M 0.91% 25
2024
Q2
Sell
-4,225
Closed -$2.19M 626
2024
Q1
$2.19M Sell
4,225
-12
-0.3% -$5.97K 0.34% 70
2023
Q4
$2M Sell
4,237
-79
-2% -$36.5K 0.33% 80
2023
Q3
$1.88M Buy
4,316
+139
+3% +$63K 0.34% 80
2023
Q2
$1.86M Sell
4,177
-88
-2% -$40.6K 0.32% 81
2023
Q1
$1.96M Buy
4,265
+171
+4% +$81.4K 0.35% 74
2022
Q4
$2.1M Buy
+4,094
New +$2.08M 0.36% 56
2022
Q2
Sell
-450
Closed -$221K 581
2022
Q1
$221K Buy
+450
New +$206K 0.02% 525
2021
Q2
Sell
-11,249
Closed -$4.04M 560
2021
Q1
$4.04M Sell
11,249
-406
-3% -$131K 0.45% 35
2020
Q4
$3.52M Sell
11,655
-1,731
-13% -$531K 0.5% 53
2020
Q3
$3.6M Sell
13,386
-958
-7% -$258K 0.51% 38
2020
Q2
$3.77M Buy
14,344
+231
+2% +$61.6K 0.61% 31
2020
Q1
$3.2M Buy
14,113
+866
+7% +$236K 0.63% 33
2019
Q4
$4M Buy
13,247
+1,153
+10% +$317K 0.54% 50
2019
Q3
$2.9M Buy
+12,094
New +$3.31M 0.41% 83
2019
Q2
Sell
-1,257
Closed -$361K 427
2019
Q1
$361K Buy
1,257
+180
+17% +$52.1K 0.05% 368
2018
Q4
$283K Sell
1,077
-11,083
-91% -$3.05M 0.04% 379
2018
Q3
$3.33M Sell
12,160
-20
-0.2% -$5.19K 0.44% 71
2018
Q2
$2.9M Buy
+12,180
New +$2.82M 0.41% 79
2016
Q1
Sell
-3,285
Closed -$458K 361
2015
Q4
$458K Buy
+3,285
New +$453K 0.09% 233

Other funds holding ELV

Cornercap Investment Counsel's ELV Position: Q4 2025 in Review

Cornercap Investment Counsel reduced its Elevance Health (ELV) stake by 1.3% in Q4 2025, selling an estimated $17.6K and leaving 3,808 shares worth $1.33M. The position accounts for 0.66% of the portfolio, ranked #79.

Cornercap Investment Counsel first reported a position in ELV in Q4 2015 and has held it in 23 quarters since. The position peaked at $4.04M in Q1 2021. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Cornercap Investment Counsel held 3,808 shares of Elevance Health worth $1.33M as of Q4 2025.
  • Cornercap Investment Counsel sold 52 Elevance Health shares in Q4 2025, an estimated $17.6K.
  • Elevance Health made up 0.66% of Cornercap Investment Counsel's portfolio in Q4 2025, its #79 holding.
  • Cornercap Investment Counsel first reported a position in Elevance Health in Q4 2015 and has held it in 23 quarters since.
  • Cornercap Investment Counsel's Elevance Health position peaked at $4.04M in Q1 2021.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Cornercap Investment Counsel's 13F filing for Q4 2025, filed 13 Feb 2026.